As of 2025-07-08, the Intrinsic Value of ChZPSN-Profnastil PAO (PRFN.ME) is 9.23 RUB. This PRFN.ME valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 6.33 RUB, the upside of ChZPSN-Profnastil PAO is 45.90%.
The range of the Intrinsic Value is 8.51 - 10.13 RUB
Based on its market price of 6.33 RUB and our intrinsic valuation, ChZPSN-Profnastil PAO (PRFN.ME) is undervalued by 45.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 8.51 - 10.13 | 9.23 | 45.9% |
| DCF (Growth 10y) | 10.43 - 12.13 | 11.20 | 77.0% |
| DCF (EBITDA 5y) | 9.12 - 10.88 | 9.93 | 56.9% |
| DCF (EBITDA 10y) | 10.78 - 12.60 | 11.62 | 83.6% |
| Fair Value | 12.58 - 12.58 | 12.58 | 98.87% |
| P/E | 1.63 - 6.44 | 3.90 | -38.4% |
| EV/EBITDA | 3.33 - 5.82 | 4.47 | -29.3% |
| EPV | 1.84 - 1.95 | 1.90 | -70.0% |
| DDM - Stable | 1.72 - 2.70 | 2.21 | -65.1% |
| DDM - Multi | 5.13 - 6.23 | 5.63 | -11.1% |
| Market Cap (mil) | 5,303.02 |
| Beta | -0.09 |
| Outstanding shares (mil) | 838.29 |
| Enterprise Value (mil) | 4,720.19 |
| Market risk premium | 11.68% |
| Cost of Equity | 20.62% |
| Cost of Debt | 5.50% |
| WACC | 18.53% |